Diabetes News and Research

Latest Diabetes News and Research

Semaglutide vs. liraglutide: Head-to-head study reveals a diabetes risk difference

Researchers compared semaglutide with liraglutide in 57,456 insured adults without recorded diabetes or cardiovascular disease who initiated formulations indicated for chronic weight management. Semaglutide users had a lower risk of incident diabetes, particularly beyond six months of follow-up, but limited cardiovascular events prevented a precise comparison of cardiovascular risk.

20 Jul 2026

Semaglutide fuels rapid growth in US GLP-1RA use as payments rise

Nationally representative US data show GLP-1RA use rose 230% among adults with diabetes and 643% among those without reported diabetes between 2017 and 2022, largely driven by semaglutide. Mean annual out-of-pocket payments decreased, but mean total annual payments per user increased, raising concerns about long-term affordability.

20 Jul 2026

High doses of caffeine from energy drinks cause cardiovascular harm

Previous studies have found that caffeine is the world's most popular stimulant and psychoactive substance, and coffee is the most common way people consume caffeine.

20 Jul 2026

GLP-1 weight-loss drugs may also reduce binge eating

Research indicates GLP-1RAs may effectively reduce binge eating severity, offering a complementary approach to existing psychological therapies for obesity.

20 Jul 2026

Filtered coffee links to slower biological aging while instant coffee shows the opposite

Filtered coffee consumption was associated with slower biological aging, while instant coffee was linked to faster aging in UK Biobank participants. The cross-sectional findings do not prove causation, but they suggest that brewing method may influence coffee’s relationship with aging biomarkers.

20 Jul 2026

Vitamin D falls short as an add-on treatment for endometriosis

An eight-week randomized trial of 66 women found that adjunctive vitamin D did not significantly or meaningfully improve endometriosis pain or quality of life compared with placebo during dienogest therapy. The results do not support routine short-term adjunctive supplementation, although the brief trial and absence of post-treatment vitamin D measurements leave longer-term effects uncertain.

19 Jul 2026

Frequent TV watching may harm long-term brain health

"Turn off that TV, it'll rot your brain!" has been a household refrain for decades. While "rot" might be too strong a term, researchers are finding that the overall sentiment could have some merit.

17 Jul 2026

Study reveals how adolescent brain remodeling reshapes memory retrieval

Scientists have long known that the human brain continues developing well beyond the teenage years, with important changes involving decision-making and emotional regulation extending into the mid-to-late 20s.

17 Jul 2026

Popular diabetes drugs do not alter the risk of developing a blinding eye condition

An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs) - a type of medication that mimics the GLP-1 hormone - to lower blood sugar and support weight loss. Some research has suggested that their use can reduce the risk of developing other diseases.

17 Jul 2026

Diet helps people lose weight regardless of genetic obesity risk

A study reveals dietary coaching aids weight loss equally in individuals with high and low genetic obesity risk, challenging genetic determinism in weight loss.

17 Jul 2026

Maternal diets high in UPFs may influence children’s health years later

A narrative review of 84 publications links higher ultra-processed food intake during pregnancy and early childhood with poorer diet quality, maternal complications, childhood obesity, and potential immune, metabolic, and neurodevelopmental effects. The authors identify possible microbiome and biopsychosocial pathways but emphasize that the predominantly observational evidence cannot establish causality.

17 Jul 2026

Study links expanding GLP-1 use with rising overall costs

As use of GLP-1s surged across the U.S., average total payments per user also climbed sharply, according to a new Northwestern University study that analyzed national trends in GLP-1 use and spending between 2017 and 2022.

16 Jul 2026

Early PFAS exposure linked to childhood intestinal inflammation

Researchers at the Icahn School of Medicine at Mount Sinai have found that exposure to per- and polyfluoroalkyl substances (PFAS), commonly known as "forever chemicals," during pregnancy and early life is associated with increased intestinal inflammation during childhood.

16 Jul 2026

AI-based nursing interventions can improve care of people living with chronic illnesses

Artificial intelligence (AI) is helping nurses better predict health problems before they become emergencies, according to a new review of existing research published in JMIR Nursing.

16 Jul 2026

Study finds some sweeteners can slow the growth of gut bacteria

Cambridge researchers have shown how commonly-used sweeteners slow the growth of certain gut bacteria.

16 Jul 2026

WHO updates guidelines to reduce risk of dementia worldwide

The World Health Organization (WHO) today released updated guidelines on reducing the risk of cognitive decline and dementia, providing countries with evidence-based recommendations to help prevent or delay the onset of dementia across the life course.

16 Jul 2026

Blood ketone threshold may help predict weight loss success

Achieving and sustaining a blood ketone level of 0.5 mmol/L is crucial for weight loss in ketogenic diets, offering a new approach to dietary monitoring.

16 Jul 2026

New body mass index could overcome limitations of BMI

The Consistent Body Mass Index (CBMI) offers a promising alternative to traditional BMI, aligning with waist-to-height ratio for better body size assessment.

16 Jul 2026

Fractyl Health reports positive randomized data from REMAIN-1 Midpoint Cohort demonstrating durable weight maintenance one year after GLP-1 discontinuation

Fractyl Health, Inc. (Fractyl), a clinical-stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D), today announced positive one-year results from its REMAIN-1 Midpoint Cohort (“Midpoint Cohort”).

16 Jul 2026

Epidurals during labor show no significant risks to newborns

Having an epidural during labor is not associated with clinically significant increased risks of harm to newborn babies, including brain injury, severe breathing problems, sepsis and death, or cerebral palsy later in childhood.

15 Jul 2026